Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

A promising new treatment accelerates myelin repair, potentially restoring vision and improving brain function in people with ...

The Crafoord Prize in Polyarthritis 2025, worth 6 million Swedish kronor, is awarded to Christopher Goodnow, Australia, and David Nemazee, USA. They ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

Sanofi has removed a clutch of programs from its clinical pipeline, scratching out entries for its late-phase BTK inhibitor and phase 1 prospects linked to the multibillion-dollar takeovers of Ablynx, ...

Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and ...

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ...

Celltrion, a leading Korean biotechnology firm, has successfully developed Zymfentra, a subcutaneous version of the company’s ...

Scientists have long suspected the keto diet might be able to calm an overactive immune system and help some people with ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

Researchers have found a promising drug candidate that could help restore vision in individuals with multiple sclerosis (MS) and other neurological conditions that damage neurons.